Skip to main content

Evan Jones, Domingo Messerli, Maureen Loftus

Premium
Signature Genomic Laboratories has named Evan Jones, the principal of jVen Capital, which recently invested in the company, to serve on its board of directors.
 
Jones was co-founder and chairman of the board of directors of Digene, which was acquired last year by Qiagen. He is now chairman of the board of directors for the Children’s Research Institute at the Children’s National Medical Center. He also is chairman of the Campaign for Public Health, and a member of the board of directors and executive committee at Research!America.
 

 
Tecan has named Domingo Messerli to be head of the company’s sample management business and a member of its executive board. Messerli was CEO of Elektrizitäts for three years and he held various management positions at the pharmaceutical, food, and chemical company Glatt.
 

 
Maureen Loftus has joined IBT Laboratories as president and chief operating officer, the company said this week.
 
Loftus most recently served as president of the Bode Technology Group, a forensic DNA analysis firm. Prior to that, she was chief operating officer of Identico Systems, a provider of biometric-enabled identity-verification systems.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.